Literature DB >> 8755518

A complex of nuclear proteins mediates SR protein binding to a purine-rich splicing enhancer.

J M Yeakley1, J P Morfin, M G Rosenfeld, X D Fu.   

Abstract

A purine-rich splicing enhancer from a constitutive exon has been shown to shift the alternative splicing of calcitonin/CGRP pre-mRNA in vivo. Here, we demonstrate that the native repetitive GAA sequence comprises the optimal enhancer element and specifically binds a saturable complex of proteins required for general splicing in vitro. This complex contains a 37-kDa protein that directly binds the repetitive GAA sequence and SRp40, a member of the SR family of non-snRNP splicing factors. While purified SR proteins do not stably bind the repetitive GAA element, exogenous SR proteins become associated with the GAA element in the presence of nuclear extracts and stimulate GAA-dependent splicing. These results suggest that repetitive GAA sequences enhance splicing by binding a protein complex containing a sequence-specific RNA binding protein and a general splicing activator that, in turn, recruit additional SR proteins. This type of mechanism resembles the tra/tra-2-dependent recruitment of SR proteins to the Drosophila doublesex alternative splicing regulatory element.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755518      PMCID: PMC38789          DOI: 10.1073/pnas.93.15.7582

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Alternative splicing of a human alpha-tropomyosin muscle-specific exon: identification of determining sequences.

Authors:  I R Graham; M Hamshere; I C Eperon
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

2.  SR proteins: a conserved family of pre-mRNA splicing factors.

Authors:  A M Zahler; W S Lane; J A Stolk; M B Roth
Journal:  Genes Dev       Date:  1992-05       Impact factor: 11.361

3.  Sex-specific splicing and polyadenylation of dsx pre-mRNA requires a sequence that binds specifically to tra-2 protein in vitro.

Authors:  M L Hedley; T Maniatis
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

Review 4.  Biochemical mechanisms of constitutive and regulated pre-mRNA splicing.

Authors:  M R Green
Journal:  Annu Rev Cell Biol       Date:  1991

5.  An ATP-independent complex commits pre-mRNA to the mammalian spliceosome assembly pathway.

Authors:  S Michaud; R Reed
Journal:  Genes Dev       Date:  1991-12       Impact factor: 11.361

6.  The role of branchpoint and 3'-exon sequences in the control of balanced splicing of avian retrovirus RNA.

Authors:  X D Fu; R A Katz; A M Skalka; T Maniatis
Journal:  Genes Dev       Date:  1991-02       Impact factor: 11.361

7.  Exon as well as intron sequences are cis-regulating elements for the mutually exclusive alternative splicing of the beta tropomyosin gene.

Authors:  D Libri; M Goux-Pelletan; E Brody; M Y Fiszman
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

8.  Alternative processing of bovine growth hormone mRNA is influenced by downstream exon sequences.

Authors:  R K Hampson; L La Follette; F M Rottman
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

9.  In vitro splicing of cardiac troponin T precursors. Exon mutations disrupt splicing of the upstream intron.

Authors:  T A Cooper
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

10.  Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.

Authors:  V Campuzano; L Montermini; M D Moltò; L Pianese; M Cossée; F Cavalcanti; E Monros; F Rodius; F Duclos; A Monticelli; F Zara; J Cañizares; H Koutnikova; S I Bidichandani; C Gellera; A Brice; P Trouillas; G De Michele; A Filla; R De Frutos; F Palau; P I Patel; S Di Donato; J L Mandel; S Cocozza; M Koenig; M Pandolfo
Journal:  Science       Date:  1996-03-08       Impact factor: 47.728

View more
  49 in total

1.  SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.

Authors:  X Li; M E Shambaugh; F M Rottman; J A Bokar
Journal:  RNA       Date:  2000-12       Impact factor: 4.942

2.  Multiple splicing defects in an intronic false exon.

Authors:  H Sun; L A Chasin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Combinatorial control of a neuron-specific exon.

Authors:  E F Modafferi; D L Black
Journal:  RNA       Date:  1999-05       Impact factor: 4.942

4.  Phosphorylated RNA polymerase II stimulates pre-mRNA splicing.

Authors:  Y Hirose; R Tacke; J L Manley
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

5.  Reversible inhibition of the second step of splicing suggests a possible role of zinc in the second step of splicing.

Authors:  Noam Shomron; Hadar Malca; Ida Vig; Gil Ast
Journal:  Nucleic Acids Res       Date:  2002-10-01       Impact factor: 16.971

Review 6.  Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.

Authors:  Zhi-Ming Zheng
Journal:  J Biomed Sci       Date:  2004 May-Jun       Impact factor: 8.410

7.  Pri-miR-17-92a transcript folds into a tertiary structure and autoregulates its processing.

Authors:  Saikat Chakraborty; Shabana Mehtab; Anand Patwardhan; Yamuna Krishnan
Journal:  RNA       Date:  2012-03-26       Impact factor: 4.942

8.  A complex intronic splicing enhancer from the c-src pre-mRNA activates inclusion of a heterologous exon.

Authors:  E F Modafferi; D L Black
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

9.  Genome-Wide Analysis of Heat-Sensitive Alternative Splicing in Physcomitrella patens.

Authors:  Chiung-Yun Chang; Wen-Dar Lin; Shih-Long Tu
Journal:  Plant Physiol       Date:  2014-04-28       Impact factor: 8.340

10.  A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly.

Authors:  Z M Zheng; M Huynen; C C Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.